Skip to content
OpenCapital
Get started

Biogen BIIB Contract manufacturing revenue — Total Revenue

Other product segments

TYSABRI
$441.5M+15.7%
SPINRAZA
$374M-11.8%
VUMERITY
$179M+29.0%
AVONEX
$163.2M-2.2%
SKYCLARYS
$150.7M+21.6%
BENEPALI
$122.1M+9.7%
TECFIDERA
$109.5M-46.9%
PLEGRIDY
$64.3M+8.1%
ZURZUVAE
$55.4M+100%
IMRALDI
$49.6M+4.6%
QALSODY
$32.5M+110%
FLIXABI
$10.5M-19.8%
BYOOVIZ
$0-100%
FAMPYRA
$0-100%
FUMADERM And ADUHELM
$0-100%
TOFIDENCE
$0-100%

Similar metrics at other companies

Veracyte logo
VCYTContract manufacturing and testing — Total Revenue
$0-100%
Elanco Animal Health Inc. logo
ELANContract Manufacturing — Revenue
$19M+58.3%
Alkermes logo
ALKSManufacturing Revenue — Revenue
$4.07M-76.5%
Rocky Brands logo
RCKYContract Manufacturing — Revenue (Gross)
$3.31M+25.0%
Sarepta Therapeutics, Inc. logo
SRPTContract Manufacturing Revenue — Revenue From Collaborative Arrangement Excluding Revenue From Contract With Customer
$31.11M+79.0%
CorMedix logo
CRMDContract revenue — Total Revenue
$5.51M—

Other financials

Income statement

See full
Revenue$2.5B+1.9%
Gross profit$1.8B+0.8%
Operating income$610.7M—
Net income$319.5M+32.8%
EPS (diluted)$2.15+31.1%

Balance sheet

See full
Cash & equivalents$3.4B+30.2%
Total debt$6.6B+34.7%
Total equity$18.7B+9.9%
Total assets$29.5B+5.2%

Cash flow

See full
Operating cash flow$645.5M+149%
CapEx$51.2M+38.0%
Free cash flow$594.3M+167%

Valuation

See full
Market cap$31.89B+72.3%
Enterprise value$35.07B+57.0%
P/E22.5×+10.4×
P/S3.2×+1.4×

Profitability

See full
Gross margin75.5%-0.1pp
Operating margin22.9%—
Net margin14.3%-0.8pp
FCF margin24.4%-0.4pp

Returns & leverage

See full
Return on equity8%-1.2pp
Debt / equity0.4×+0.1×
Current ratio3.1×+1.6×

Where this comes from

Reported directly by Biogen in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Biogen’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biogen's contract manufacturing revenue — total revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biogen's contract manufacturing revenue — total revenue?
Biogen (BIIB) reported contract manufacturing revenue — total revenue of $237.2M in Q1 2026.
How has Biogen's contract manufacturing revenue — total revenue changed year-over-year?
Biogen's contract manufacturing revenue — total revenue decreased by 16.0% year-over-year, from $282.3M to $237.2M.
What is the long-term trend for Biogen's contract manufacturing revenue — total revenue?
Over 4 years (2021 to 2025), Biogen's contract manufacturing revenue — total revenue has grown at a 12.3% compound annual growth rate (CAGR), from $427.7M to $679.4M.
What does contract manufacturing revenue — total revenue mean?
This metric represents the total gross revenue generated from providing contract manufacturing services to third-party pharmaceutical or biotechnology partners. It reflects the company's ability to monetize excess manufacturing capacity and technical expertise by producing drugs or biologics for other firms. This revenue stream is distinct from the company's core proprietary product sales and serves as a secondary source of income.